* Prestige Consumer Healthcare Inc PBH.N PBH is expected
to show a rise in quarterly revenue when it reports results on
May 5.
* The Tarrytown New York-based company is expected to
report a
8.6% increase in revenue to $258.241 million from $237.76
million a year ago, according to the mean estimate from 6
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Prestige Consumer
Healthcare Inc is for earnings of 89 cents per share. For the
same quarter last year, the company reported earnings of 79
cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Prestige
Consumer
Healthcare Inc is $68.5, above its last closing price
of $54.44.
* Previous quarterly performance (using preferred earnings
measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Dec. 31 2021 0.88 0.88 0.99 Beat 12.1
Sep. 30 2021 0.99 0.99 0.89 Missed -9.8
Jun. 30 2021 0.87 0.87 1.14 Beat 31.5
Mar. 31 2021 0.79 0.78 0.79 Beat 1.3
Dec. 0.77 0.77 0.81 Beat 5.6
31 2020
Sep. 30 2020 0.72 0.72 0.78 Beat 8.8
Jun. 30 2020 0.70 0.70 0.86 Beat 22.9
Mar. 31 2020 0.75 0.74 0.82 Beat 11.2
This summary was machine generated May 4 at 02:01 GMT. All
figures in US dollars unless otherwise stated